Cargando…
Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence
Hepatitis A virus (HAV) infections continue to represent a significant disease burden causing approximately 200 million infections, 30 million symptomatic illnesses and 30,000 deaths each year. Effective and safe hepatitis A vaccines have been available since the early 1990s. Initially developed for...
Autores principales: | Herzog, Christian, Van Herck, Koen, Van Damme, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078665/ https://www.ncbi.nlm.nih.gov/pubmed/33325760 http://dx.doi.org/10.1080/21645515.2020.1819742 |
Ejemplares similares
-
Hepatitis B Vaccines
por: Pattyn, Jade, et al.
Publicado: (2021) -
Long-Term T-Cell-Mediated Immunologic Memory to Hepatitis B Vaccine in Young Adults Following Neonatal Vaccination.
por: Saffar, Hiva, et al.
Publicado: (2014) -
Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis
por: Whitford, Kate, et al.
Publicado: (2018) -
Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine
por: Van Damme, Pierre, et al.
Publicado: (2017) -
Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A
por: Hussain, Zahid, et al.
Publicado: (2011)